A cancer diagnosis can bring many questions, especially when your oncologist mentions newer treatment options such as immunotherapy. Unlike conventional treatments that directly attack cancer cells, immunotherapy for cancer works by helping the body's immune system recognize and respond to cancer.

For some patients, immunotherapy can become an important part of a broader cancer treatment plan. For others, it may not be appropriate. The decision depends on factors such as the cancer type, stage, tumour characteristics, biomarker results, previous treatments and the person's overall health.

If you are exploring cancer treatment in Hyderabad, understanding how immunotherapy works and what treatment may involve can make discussions with an oncology team easier.

This guide explains the basics of cancer immunotherapy, who may be considered for it, how treatment is usually given, possible side effects, and what patients should discuss with an oncologist.

What Is Immunotherapy for Cancer?

Immunotherapy is a type of cancer treatment that helps the immune system recognize and fight cancer cells.

The immune system normally protects the body from infections and other threats. However, cancer cells can sometimes avoid being detected or can interfere with immune responses.

Immunotherapy aims to overcome some of these mechanisms. Depending on the treatment, it may remove signals that suppress immune cells, help immune cells recognize cancer more effectively, or use specially designed medicines to target cancer-related biological processes.

Unlike the term "cancer treatment" might suggest, immunotherapy is not one single medicine. It includes several different treatment approaches.

Patients considering immunotherapy treatment in Hyderabad should therefore ask their oncologist which specific type is being considered and why it may be appropriate for their cancer.

For a broader overview of oncology services, see oncology and cancer treatment options.

How Does Cancer Immunotherapy Work?

Cancer cells can sometimes hide from the immune system or send signals that reduce immune activity.

One important approach is called an immune checkpoint inhibitor.

Think of immune checkpoints as natural "brakes" that prevent the immune system from becoming excessively active. Some cancer cells can take advantage of these checkpoints to avoid immune attack.

Checkpoint inhibitor medicines block particular checkpoint signals, allowing immune cells to respond more strongly against cancer cells.

Other forms of immunotherapy work differently.

Depending on the cancer and treatment, immunotherapy may include:

• Immune checkpoint inhibitors
• Monoclonal antibodies
• T-cell transfer therapies
• Cancer treatment vaccines
• Immune system modulators
• Other emerging immune-based treatments

The specific medicine and treatment strategy depend on the cancer and the patient's clinical characteristics.

Which Cancers Can Be Treated With Immunotherapy?

Immunotherapy is used for selected cancers, but it is not suitable for every cancer or every patient.

Depending on the specific medicine and clinical situation, immunotherapy may be considered for cancers such as:

• Lung cancer
• Melanoma
• Kidney cancer
• Bladder cancer
• Head and neck cancers
• Certain breast cancers
• Some colorectal cancers
• Certain blood cancers
• Other cancers where an approved immunotherapy is appropriate

Whether a person can receive immunotherapy depends on the cancer diagnosis, stage, molecular or biomarker findings, previous treatments and overall health.

Medicover Cancer Institute, Hitec City, Hyderabad lists medical oncology among its cancer services and states that medical oncology may include chemotherapy, immunotherapy, targeted therapy and hormone therapy depending on the patient's diagnosis and treatment plan.

Patients can also explore the Oncology department at Medicover Cancer Institute, Hitec City.

Who May Benefit From Immunotherapy?

There is no simple checklist that can determine whether someone will benefit from immunotherapy.

An oncologist may consider several factors, including:

1. Type of cancer

Different cancers respond differently to immune-based treatments.

2. Cancer stage

The stage describes how extensive the cancer is and whether it has spread to other parts of the body. Treatment recommendations can change significantly depending on the stage.

3. Biomarker or molecular test results

Some cancers have biological characteristics that can help doctors determine whether a particular immunotherapy may be useful.

These tests may examine proteins, genes or other features of tumour cells.

4. Previous cancer treatment

The treatment plan may depend on whether the patient has already received surgery, chemotherapy, radiation therapy, targeted therapy or another systemic treatment.

5. Overall health

Other medical conditions, medications and the patient's general health can influence treatment decisions.

6. Treatment goals

The purpose of treatment also matters. Immunotherapy may be considered with different objectives depending on the cancer, such as controlling disease, reducing recurrence risk in selected situations or treating advanced disease.

Because these factors vary considerably, immunotherapy eligibility should be determined by a qualified oncology team rather than by symptoms alone.

What Tests May Be Needed Before Immunotherapy?

Before starting treatment, the oncology team generally needs enough information to understand the cancer and determine whether the proposed treatment is appropriate.

Depending on the diagnosis, evaluation may include:

• Medical history and physical examination
• Biopsy or pathology reports
• Blood tests
• CT or MRI scans
• PET-CT when clinically indicated
• Molecular or biomarker testing
• Assessment of previous treatments
• Evaluation of organ function and general health

Medicover Cancer Institute states that its cancer-care services include diagnostic facilities such as 4D PET-CT, MRI, X-ray, mammography and ultrasound, depending on clinical requirements.

Patients can learn more through the Medicover Cancer Institute hospital profile in Hitec City.

Immunotherapy vs Chemotherapy: What Is the Difference?

Patients often ask whether immunotherapy is the same as chemotherapy.

It is not.

Chemotherapy uses medicines that directly affect cancer cells, particularly cells that divide rapidly. It can also affect some healthy rapidly dividing cells, which contributes to several common chemotherapy side effects.

Immunotherapy, on the other hand, works by modifying or strengthening immune responses against cancer.

The two treatments may sometimes be used together rather than treated as alternatives. The appropriate combination depends on the cancer and the evidence supporting a particular treatment strategy.

You can read more about chemotherapy treatment and cancer care.

Can Immunotherapy Be Combined With Other Cancer Treatments?

Yes. In selected situations, immunotherapy may be combined with other treatments.

A cancer treatment plan may involve:

• Immunotherapy
• Chemotherapy
• Radiation therapy
• Surgery
• Targeted therapy
• Hormone therapy
• Supportive or palliative care

The sequence can vary. For example, one patient may receive surgery followed by additional treatment, while another may receive systemic therapy before surgery.

At Medicover Cancer Institute, published information describes a multidisciplinary cancer-care model involving medical oncology, surgical oncology and radiation oncology.

Relevant resources include:

• Cancer surgery and surgical oncology
• Radiation therapy and radiotherapy
• Targeted cancer therapy
• Precision oncology and biomarker-based treatment

What Should You Expect During Immunotherapy?

Many immunotherapy medicines are administered through an intravenous infusion, although the method depends on the specific treatment.

A typical treatment visit may involve:

1. Checking your health and reviewing symptoms
2. Reviewing blood-test results when required
3. Confirming that treatment can proceed
4. Administering the prescribed medicine
5. Monitoring during or after treatment
6. Providing instructions for symptoms to watch for
7. Scheduling the next treatment visit

Treatment frequency varies. Some immunotherapy medicines are given every few weeks, while others follow different schedules.

The number of treatments and total treatment duration depend on the specific medicine, cancer type, treatment response, side effects and the treatment plan established by the oncology team.

There is no universal "number of immunotherapy cycles" that applies to every patient.

What Are the Side Effects of Immunotherapy?

One of the most important things patients should understand is that immunotherapy side effects can be different from those associated with chemotherapy.

Because immunotherapy activates or modifies the immune response, the immune system can sometimes affect healthy tissues as well. These are often called immune-related adverse effects.

Possible side effects include:

• Fatigue
• Skin rash or itching
• Fever or chills
• Nausea
• Diarrhea
• Muscle or joint aches
• Headache
• Changes in thyroid or other hormone function
• Inflammation of organs
• Breathing difficulties in some cases

The type and severity of side effects vary from person to person.

Importantly, side effects can occur during treatment and, in some cases, after treatment has ended.

That is why patients should tell their oncology team about new or unusual symptoms rather than waiting for the next scheduled appointment.

Immunotherapy Warning Signs That Should Not Be Ignored

Some symptoms require prompt medical attention because they may indicate an immune-related complication or another medical problem.

Contact your cancer-care team promptly if you develop:

• New or worsening shortness of breath
• Persistent or high fever
• Severe or persistent diarrhea
• Blood in the stool
• Severe abdominal pain
• Significant skin rash or blistering
• Yellowing of the skin or eyes
• Severe weakness or unusual confusion
• Significant changes in urination
• New severe headache or neurological symptoms
• Chest pain or other serious symptoms

Severe symptoms such as difficulty breathing, severe chest pain, fainting, confusion or other signs of an acute medical emergency should be assessed urgently.

The important point is simple: do not assume every new symptom is a normal part of cancer treatment. Immunotherapy-related complications can require medical assessment and treatment.

Does Immunotherapy Work for Everyone?

No.

This is one of the most important misconceptions to avoid.

Immunotherapy has become an important treatment option for several cancers, but not every tumour responds to it. Some cancers have biological characteristics that make them less responsive, and some patients may develop resistance during treatment.

The decision to use immunotherapy should therefore be based on the individual cancer and available clinical evidence rather than the assumption that newer treatment is automatically better.

Your oncologist may discuss alternative or combined approaches depending on your diagnosis.

What Questions Should You Ask Your Oncologist?

If immunotherapy has been suggested, consider taking a written list of questions to your consultation.

Useful questions include:

• Why is immunotherapy being considered for my cancer?
• What type of immunotherapy is being recommended?
• Is biomarker testing needed?
• What is the goal of treatment?
• Will immunotherapy be given alone or with chemotherapy, radiation or another treatment?
• How often will I receive treatment?
• How long might treatment continue?
• Which side effects should I watch for?
• Who should I contact if I develop symptoms at home?
• What tests will be used to monitor my response?
• What alternatives are available if this treatment is not suitable?
• Should I consider a second oncology opinion?

Bringing your biopsy reports, imaging reports, previous treatment records, medication list and blood-test results can make the consultation more productive.

You can also explore oncology specialists and doctors available through Siris Healthcare.

Immunotherapy and Cancer Care at Medicover Cancer Institute, Hitec City

Medicover Cancer Institute in Hitec City, Hyderabad describes itself as a specialised cancer treatment centre providing medical oncology, surgical oncology and radiation oncology services. Its published cancer-care information includes immunotherapy among the available treatment approaches, alongside chemotherapy, targeted therapy, hormone therapy, radiation therapy and cancer surgery.

The institute also lists specialised oncology areas including breast oncology, uro-oncology, thoracic oncology and hemato-oncology, as well as diagnostic and supportive services.

For patients researching cancer treatment in Hitec City Hyderabad, the hospital's location is opposite Cyber Gateway and beside IBIS Hotel in HUDA Techno Enclave.

You can review:

• Medicover Cancer Institute, Hitec City, Hyderabad
• Oncology services at Medicover Cancer Institute
• Medicover Cancer Institute FAQs
• Oncoplastic surgery services
• Bone marrow transplant services

The availability of a particular medicine, treatment protocol or specialist should always be confirmed directly with the treating oncology team.

Is Immunotherapy Expensive?

The cost of immunotherapy in Hyderabad can vary substantially.

There is no single price that applies to all patients because expenses may depend on:

• The immunotherapy medicine
• Dose and treatment schedule
• Cancer type and stage
• Number of treatment cycles
• Required diagnostic and biomarker testing
• Blood tests and imaging
• Hospital or day-care charges
• Other treatments received alongside immunotherapy
• Management of treatment-related complications

For this reason, online "fixed immunotherapy cost" figures can be misleading.

A patient should ask the hospital or oncology team for a treatment-specific estimate after the diagnosis and treatment plan have been reviewed.

When Should You Seek an Oncology Consultation?

You do not need to wait until symptoms become severe to discuss a confirmed cancer diagnosis.

An oncology consultation may be appropriate when:

• A biopsy has confirmed cancer
• Imaging strongly suggests malignancy
• A cancer diagnosis has been made elsewhere
• Treatment options need to be discussed
• You have been advised to consider immunotherapy
• You want to understand whether biomarker testing is appropriate
• You are considering a second opinion
• Cancer has returned or progressed
• You need help understanding an existing treatment plan

A second opinion can sometimes help patients understand their diagnosis and treatment options more clearly, particularly before major or complex treatment decisions.

Frequently Asked Questions About Immunotherapy for Cancer

1. What is immunotherapy for cancer?

Immunotherapy is a cancer treatment that helps the immune system recognize or respond to cancer cells. Different forms work in different ways, and suitability depends on the individual cancer.

2. Which cancers respond to immunotherapy?

Immunotherapy is used for selected cancers, including certain lung, melanoma, kidney, bladder and head and neck cancers, among others. Whether it is appropriate depends on the specific cancer, stage, biomarkers and treatment history.

3. Is immunotherapy better than chemotherapy?

Neither treatment is universally "better." They work differently, and some patients may receive immunotherapy, chemotherapy, or a combination depending on the cancer and treatment evidence.

4. What are the common side effects of immunotherapy?

Possible side effects include fatigue, skin changes, fever, nausea, diarrhea and inflammation affecting different organs. Some immune-related side effects can be serious, so new symptoms should be reported to the treating team.

5. How is immunotherapy given?

Many immunotherapy medicines are given through an intravenous infusion, although the route and schedule depend on the specific medicine. Treatment may be given at regular intervals or in cycles.

6. Can immunotherapy be combined with chemotherapy?

Yes. Depending on the cancer, immunotherapy may be combined with chemotherapy, radiation therapy, targeted therapy or surgery. The combination must be selected by the oncology team based on the individual diagnosis.

7. How long does immunotherapy treatment last?

There is no standard duration for everyone. Treatment frequency and duration depend on the medicine, cancer type, treatment response, side effects and the oncologist's treatment plan.

8. Should I get a second opinion before starting immunotherapy?

A second opinion can be reasonable when you want another specialist's assessment of the diagnosis, biomarker results or proposed treatment plan. Carrying complete pathology, imaging and previous treatment records can help the reviewing oncologist.

Final Takeaway

Immunotherapy for cancer has changed the treatment landscape for several types of cancer, but it is not a universal treatment and should not be viewed as a replacement for every other form of cancer therapy.

The most important question is not simply, "Does immunotherapy work?" It is:

"Is this particular immunotherapy appropriate for my particular cancer?"

That answer depends on the cancer type, stage, pathology, biomarkers, previous treatment and overall health.

If you or a family member has been diagnosed with cancer or has been advised to consider immunotherapy, discussing the available options with a qualified oncologist is the safest way to understand the next step.

For patients looking for oncology care in Hyderabad, Medicover Cancer Institute, Hitec City provides access to medical, surgical and radiation oncology services, with immunotherapy listed among its cancer treatment options.

Medical Disclaimer

This article is intended for general educational purposes only. It does not diagnose cancer, recommend a specific treatment or replace advice from a qualified doctor. Cancer treatment is individualised, and treatment decisions should be made with an appropriately qualified oncology professional after reviewing the patient's diagnosis, pathology, imaging, medical history and overall health.